Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ATARA BIOTHERAPEUTICS, INC. (ATRA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ATARA BIOTHERAPEUTICS, INC. (ATRA), most recent 12 months reported: revenue $120.77M, net loss $16.69M, free cash flow -$50.94M. Latest balance sheet on file: liquid cash $9.87M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): REGENXBIO Inc. · IMMUNITYBIO, INC. · Beam Therapeutics Inc. · AGENUS INC · Autolus Therapeutics plc · GINKGO BIOWORKS HOLDINGS, INC. · Century Therapeutics, Inc. · KYMERA THERAPEUTICS, INC.

Stock screener

Watchlist